“Mikhail Blagosklonny: Restoring & Reguvinating The Health Of Multitudes!”

Mikhail Blagosklonny is one of the leading scientists fighting the war on cancer and anti-aging in the United States. His discoveries have been remarkable in regard to the drug he developed Rapamycin and the contributions he has made with compelling evidence of other cutting-edge scientific case studies that he has compiled into a website by the name Oncotarget. Oncotarget publishes papers and medical findings having to with oncology, pathology, immunology, microbiology, autophagy, chromosomes and cell demise. Oncotarget was founded in 2010 by Blagosklonny and Andrei V. Gudkov who are now the acting editors and chief. Both men are also professors at the same Roswell Park Cancer Institute. Oncotarget has become a well-used resource for many medical professionals when charting a course for patient treatment as it encompasses a very large and innovative archival of published documents having to deal with cancer and other aforementioned functions of the body. Its growing notoriety is in part by its astute, productive, prompt and peer-reviewed research papers and case files.

Rapamycin, known for its antifungal properties, was uncovered from Rapa Nui’s earthen soil. Rapa Nui, better known as Easter Island, lies off the Polynesian coast of Chile, on an island of the Pacific Ocean. It was discovered around 1987. Further investigation into the properties of Rapamycin concluded that it had a wide range of immunosuppressant qualities and as a result has made an excellent drug that assists the organs after transplant surgery. There has been remarkable success in the use of this macrolide compound for its ability to suppress the growth of cancer cells. The pharmaceutical has been cleared by the Food and Drug Administration and is currently being used alongside of corticosteroids and cyclosporine to counteract renal refutation. Some of the most current remedial treatments have shown very promising effects on the following conditions.

  • Therapy for treating the common Alzheimer’s disease in the elderly.
  • For augmented lifespan of a person/anti-aging properties
  • Remedy for Facial Fibroid tumor
  • Treatment of Tuberous Sclerosis Complex (benign tumors on body parts)
  • Overlaying of the Coronary Stent
  • Remedial cure of Sporadic Lymphangioleiomyomatosis (lung tumor)
  • Remedy for hemolytic-uremic syndrome (blood disease)
  • Curing of Muscular Dystrophy
  • Therapy for the skin disease, Systemic Lupus Erythematosus (inflammatory disease)

Dr. Blagosklonny has an extensive acumen in a vast array of fields but specializes in oncology, biometrics, cellular and molecular biology. He has written and published over 250 medical papers and is a regularly contributing author to many other publications, outside of Oncotarget. Mikhail is passionate about eradicating disease and thusly pain during a humans lifetime and continues his work along this matter for the betterment of health, science and humanity. After all, finding a promising cancer cure is no small feat!